Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation
EARLY_PHASE1
The purpose of this study is to determine the efficacy of aprepitant in pre...
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
PHASE2
Pre-clinical data and recently published clinical data suggest a synergisti...
Status
Completed
Location
University of Pennsylvania; Abramson Cancer Center; Lymphoma Program
A PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH A THROMBOPOIETIN RECEPTOR AGONIST AND/OR RITUXIMAB AFTER CORTICOSTEROID FIRST-LINE THERAPY
PHASE2
This is a Phase II open label, prospective, multicenter trial designed to a...
Status
Not Yet Recruiting
Location
General Hospital of Athens "Alexandra", Athens, Attica